CRISPR, Gene Editing & DNA-Repair Antibodies

Sort by

CRISPR efficiency is only part of the result. Evaluate DNA-damage signaling, repair-pathway activation, and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2, DNA-PK, γH2AX, ATM, ATR, and other key genome-stability proteins.

Collection Menu

Lane 1: 293T cells transfected with CRISPR9-Cas9; Lane 2: untransfected 293T cell lysate probed with CRISPR-Cas9 (1E8) Monoclonal Antibody, Unconjugated (bsm-52042M) at 1:1000 overnight at 4˚C. Followed by a conjugated secondary antibody. — Cas9 (1E8) Monoclonal Antibody

Catalog #1: bsm-52042m

Applications: WB, ICC/IF

Reactivity: Human, Others

Conjugate: Unconjugated

Lane 1: A431; Lane 2: HeLa; Lane 3: Jurkat; Lane 4: K562; Lane 5: MCF-7 cell lysates at 20ug per lane; probed with bsm-51266M CHK1 (2G1D5) Monoclonal Antibody at 1:1000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C. — CHK1 (2G1D5) Monoclonal Antibody

Catalog #1: bsm-51266M

Applications: WB

Reactivity: Human, Mouse

Conjugate: Unconjugated